U
Ulf Risérus
Researcher at Uppsala University
Publications - 231
Citations - 14424
Ulf Risérus is an academic researcher from Uppsala University. The author has contributed to research in topics: Insulin resistance & Metabolic syndrome. The author has an hindex of 58, co-authored 219 publications receiving 12115 citations. Previous affiliations of Ulf Risérus include Churchill Hospital.
Papers
More filters
Journal ArticleDOI
Dietary fats and prevention of type 2 diabetes.
TL;DR: The evidence suggests that replacing saturated fats and trans fatty acids with unsaturated (polyunsaturated and/or monounsaturated) fats has beneficial effects on insulin sensitivity and is likely to reduce risk of type 2 diabetes.
Journal ArticleDOI
The role of reducing intakes of saturated fat in the prevention of cardiovascular disease: where does the evidence stand in 2010?
Arne Astrup,Jørn Dyerberg,Peter Creighton Elwood,Kjeld Hermansen,Frank B. Hu,Marianne Uhre Jakobsen,Frans J. Kok,Ronald M. Krauss,Jean Michel Lecerf,Philippe Legrand,Paul J. Nestel,Ulf Risérus,Thomas A. B. Sanders,Andrew J. Sinclair,Steen Stender,Tine Tholstrup,Walter C. Willett +16 more
TL;DR: The evidence from epidemiologic, clinical, and mechanistic studies is consistent in finding that the risk of CHD is reduced when SFAs are replaced with polyunsaturated fatty acids (PUFAs), and insufficient evidence exists to judge the effect on CHD risk of replacing SFAs with MUFAs.
Journal ArticleDOI
Treatment With Dietary trans10cis12 Conjugated Linoleic Acid Causes Isomer-Specific Insulin Resistance in Obese Men With the Metabolic Syndrome
TL;DR: These results reveal important isomer-specific metabolic actions of CLA in abdominally obese humans and provide physiological insights into the role of specific dietary fatty acids as modulators of insulin resistance in humans.
Journal ArticleDOI
Effects of n−6 PUFAs compared with SFAs on liver fat, lipoproteins, and inflammation in abdominal obesity: a randomized controlled trial
Helena Bjermo,David Iggman,Joel Kullberg,Ingrid Dahlman,Lars Johansson,Lena Persson,Johan Berglund,Kari Pulkki,Samar Basu,Matti Uusitupa,Mats Rudling,Peter Arner,Tommy Cederholm,Håkan Ahlström,Ulf Risérus +14 more
TL;DR: Compared with SFA intake, n-6 PUFAs reduce liver fat and modestly improve metabolic status, without weight loss.
Journal ArticleDOI
Clinical value of the metabolic syndrome for long term prediction of total and cardiovascular mortality: prospective, population based cohort study
TL;DR: In a large, community based sample of middle aged men, the presence of the metabolic syndrome according to the definition of the NCEP gave long term prognostic information regarding total and cardiovascular mortality if the status of established risk factors for cardiovascular disease was known.